Glenmark Pharmaceuticals Ltd operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Glenmark Pharmaceuticals Ltd with three other
companies in this sector in India:
Piramal Enterprises Limited
sales of 66.10 billion Indian Rupees [US$991.48 million]
of which 54%
Torrent Pharmaceuticals Limited
(66.76 billion Indian Rupees [US$1.00 billion]
of which 100%
was Pharmaceuticals), and
Jubilant Life Sciences Limited
(58.02 billion Indian Rupees [US$870.35 million]
of which 53%
During the year ended March of 2016, sales at
Glenmark Pharmaceuticals Ltd were 76.34 billion Indian Rupees (US$1.15 billion).
increase of 15.1%
versus 2015, when the company's sales were 66.30 billion Indian Rupees.
This was the fifth consecutive year of sales increases at Glenmark Pharmaceuticals Ltd
(and since 2011, sales have increased a total of 159%).